|15.99||+0.81 / +5.34%|
Data as of 3:59pm ET
|16.50||+0.51 / +3.19%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +0.06% increase from the last price of 15.99.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.